Quantumzyme Corp. (OTC: QTZM), a biotransformation company specializing in enzyme-based solutions for pharmaceutical manufacturing, announced today that it will attend the 2026 BIO International Convention, scheduled for June 22–25, 2026, in San Diego, California. The company's representatives plan to engage in informal networking meetings with industry participants, but will not be presenting, exhibiting, sponsoring, or formally participating in the conference programming.
The BIO International Convention is a premier global gathering for biotechnology and life sciences companies, academic institutions, and industry participants across various scientific and commercial disciplines. Quantumzyme views this event as a critical opportunity to connect with peers within the biotechnology and biomanufacturing ecosystem. Naveen Kulkarni, Chief Executive Officer of Quantumzyme Corp., stated that the company's attendance is focused on listening, learning, and engaging in informal discussions with industry participants as they continue to evaluate developments relevant to their technology and long-term objectives.
Quantumzyme's attendance is limited to observation and networking activities only, consistent with the company's ongoing efforts to increase industry awareness and maintain dialogue with potential collaborators, technology partners, and other stakeholders. However, the company cautioned that there can be no assurance that discussions initiated during the conference will result in any agreements, transactions, or future business relationships. Additional information regarding the convention is available at https://convention.bio.org.
Quantumzyme Corp. is a biotransformation company focused on advancing sustainable enzyme-based solutions for pharmaceutical manufacturing. The company specializes in green chemistry, applying quantum mechanics, molecular modeling, AI-driven simulations, and computational enzyme engineering to develop biocatalysts designed to enhance efficiency, reduce waste, and support environmentally responsible production. By integrating computational modeling with laboratory validation, Quantumzyme aims to deliver scalable, cost-effective biocatalysis solutions that improve industrial sustainability.
For more information and updates, please visit www.quantumzymecorp.com and the company's profile on OTC Markets at www.otcmarkets.com/stock/QTZM.
